IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Medplus Health Services IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1398.30 Cr. The company is based in Hyderabad and caters to Pharmaceutical sector. Axis Capital , Credit Suisse Securities (India) , Edelweiss Financial Services , Nomura Financial Advisory And Securities (India) are the merchant bankers of Medplus Health Services IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th August 2021.
Medplus Health Services IPO posted revenues of ₹ 3781.80 crores and PAT of ₹ 132.74 crores in FY22 on annualised basis.
Revenue:
₹ 3,759.84 Cr.
EBITDA Margin:
9.02
% 
Net Worth: ₹ 800.98 Cr.
Market Capitalisation:
[●]
P/E:
71.52 times
P/BV: [●]
EV/EBITDA: 0.09 times
Financial results of Medplus Health Services IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-21 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 1746.49 | 1385.40 | 1565.66 | 1348.70 | |
| Net Worth | 800.98 | 590.34 | 730.55 | 527.80 | |
| Total Debt | 56.75 | 86.38 | 135.24 | 105.05 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
1879.92
3,759.84 |
1462.56 | 3069.27 | 2870.60 | |
EBITDA
EBITDA on annualised basis |
169.64
339.28 |
238.21 | 150.96 | 131.35 | |
PAT
PAT on annualised basis |
66.37
132.74 |
22.27 | 63.11 | 1.79 | |
Medplus Health Services IPO PAT Margin is 3.53 % , ROCE (Return on Capital Employed) is 13.40 % as per latest financial. The below table shows Medplus Health Services IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-21 | FY21 | FY20 | FY19 |
|---|---|---|---|---|
| EBITDA Margin (%) | 9.02 | 16.29 | 4.92 | 4.58 |
| PAT Margin (%) | 3.53 | 1.52 | 2.06 | 0.06 |
| EPS (₹) | 6.16 | 5.99 | 0.21 | 1.33 |
| ROE (%) | 8.29 | 3.77 | 8.64 | 0.34 |
| ROCE (%) | 13.40 | 26.08 | 19.87 | [●] |
| ROA (%) | 3.80 | 1.61 | 4.03 | 0.13 |
| Debt to Equity | 0.07 | 0.15 | 0.19 | 0.20 |
The market Capitalisation of Medplus Health Services IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Medplus Health Services IPO prospectus highlights an Return on Equity (ROE) of 8.29 % , Return on Assets (ROA) of 3.80 %, and an EBITDA Margin of 9.02 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Medplus Health Services IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Medplus Health Services IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Medplus Health Services IPO has a Price-to-Earnings (PE) ratio of 71.52 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Medplus Health Services IPO reported revenue of ₹ 3781.80 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Medplus Health Services IPO provide insights into sales growth, market demand, and business scalability.
Medplus Health Services recorded an EBITDA of ₹ 339.28 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Medplus Health Services Profit After Tax (PAT) is ₹ 132.74 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 3,759.84 Cr.
EBITDA Margin:
9.02
%
Net Worth: ₹ 800.98 Cr.
Market Capitalisation:
[●]
P/E:
71.52 times
P/BV: [●]
EV/EBITDA: 0.09 times
Medplus Health Services operates in Pharmaceutical and Pharmacy Retailer. The Issue is listed on BSE,NSE in Dec, 2021. Medplus Health Services IPO size was 1398.30 with Issue price of 796.00 .
Merchant Banker(s) of Medplus Health Services IPO: Axis Capital Limited , Credit Suisse Securities (India) Private Limited , Edelweiss Financial Services Limited , Nomura Financial Advisory And Securities (India) Private Limited
Medplus Health Services IPO subscription was 52.59 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Medplus Health Services IPO listed at a listing price of 1120.85 against the offer price of 796.00.
The current market price of Medplus Health Services is 874.95.
Why Us?
